Pharma business info

Dr Reddy’s Laboratories , the country's No. 2 drug manufacturer by sales, registered a forecast-hitting 88% increase in quarterly net profit as sales in its main U.S. market increased over two-folds.

Nirmal Bang has suggested ‘hold’ rating on Glenmark Pharma to attain a price target of Rs 364.

British drug manufacturer AstraZeneca declared that it has decided to slash costs by shutting its Quebec research and development plant, annihilating 132 jobs.

Poland's retail pharma market posted a drop of 24% year on year during the last month to PLN 1.4 billion in gross retail prices.